The aggravation of competition in the Russian pharmaceutical market

Recently I have been observing the activity of pharmacological agents in the field of advertising their medicines in response to similar drugs, but competing drugs or analogs (generics). So now I will limit such pathological activity.

For example, most recently, the activity of drug distributors Reduxin, which is not enough that they began to add in large quantities laudatory reviews to the drug itself (for which they already had a warning), and very noticeably began to be noted in reviews to a similar drug - Goldline. I remind you that the active substance of both drugs is the same - this Sibutramine, respectively, and the effects of the application of these drugs are similar. But the ethics between the manufacturers of the two drugs was over, so I had to take out a warning for the unhealthy activity of one drug distributor in the responses of another remedy.

It can be seen that competition in the Russian pharmaceutical market is exacerbating and the saturation limit is coming. For some drugs, there is already a trend to reduce their sales. And given that many drugs as such are not medicines (it is rather biologically active additives, but actively advertised as a means to treat various diseases), it is clear that sooner or later the insight of consumers will come and sales will fall. And it's nice to eat a meal, expensive cars are bought and something should be reported to foreign suppliers, you have to apply, including dishonest methods. Previously, this was not observed and competitors were not stoked, but in war as in war.

Of course, if a person shares his unbiased opinion about treatment with various drugs, then such a response will be left as helping to form his opinion about the drug, including specialists. But the activity of agents of influence will be limited, and tough.

And I want to say to advertisers that their unhealthy activity in promoting drugs by placing customized reviews I see and first I make warnings, and then their preparations fall into black list with greater restrictions on subsequent additions of reviews.Even if this is a positive experience of using your drug by real people (although I'm trying to filter the agents of influence and their orderly reviews, which are written according to the template), this is excuse the fee for your twists. Advertising and real reviews in my Directory will be divided and so will always be.